Yeasts cause a spectrum of diseases that range from colonization to uniformly fatal invasive disease.
| Test Name and Number | Recommended Use | Limitations | Follow Up |
|---|---|---|---|
| Fungal Culture 0060149 Method: Culture/Identification |
Gold standard for diagnosing fungal infection |
Notify laboratory if Malassezia furfur is suspected |
|
| Fungal Stain, KOH with Calcofluor White 2004589 Method: Microscopy |
Identify fungus from fungal smear (eg, yeast, aseptate hyphae, septate hyphae) |
Difficult to classify type of fungus from a smear |
|
| India Ink Stain 2004593 Method: Microscopy |
Identify encapsulated yeast (eg, Cryptococcus) |
||
| Blood Culture, Fungal 0060070 Method: Continuous Monitoring Blood Culture/Identification |
Gold standard for diagnosing fungi as agent of infection in blood |
Wide range of reported sensitivity for yeast (40-90%) |
|
| Fungal Culture, Skin, Hair or Nails 0060728 Method: Culture/Identification |
Gold standard for diagnosing fungi as agent of infection in skin, hair, or nails |
||
| Fungal (Mould/Yeast) Identification 0060163 Method: Identification. Methods may include biochemical, mass spectrometry, or sequencing. |
Identify fungal agent responsible for infection |
||
| Histoplasma Antigen by EIA, Serum 0092522 Method: Semi-quantitative Enzyme Immunoassay |
Diagnose and monitor response to therapy in Histoplasma-caused disease |
Rarely positive in chronic disease |
|
| Histoplasma Antigen Detection EIA, Urine 2006110 Method: Qualitative Enzyme Immunoassay |
Diagnose and monitor response to therapy in Histoplasma-caused disease |
||
| Histoplasma capsulatum Identification by DNA Probe 0062226 Method: Nucleic Acid Probe |
Rapid test for identifying H. capsulatum (yeast or mold form) from pure isolate |
Chrysosporium anamorph Nannizziopsis vriesii may cross-react with H. capsulatum AccuProbe® |
|
| Cryptococcus Antigen, Serum 0050196 Method: Semi-quantitative Enzyme Immunoassay |
Confirm C. neoformans as infectious agent of invasive cryptococcal disease |
||
| Cryptococcus Antigen, CSF 0050195 Method: Semi-quantitative Enzyme Immunoassay |
Confirm C. neoformans as infectious agent of meningitis |
||
| (1,3)-Beta-D-Glucan (Fungitell®) 2002434 Method: Semi-Quantitative Colorimetry |
Aid in diagnosis of invasive Candida infections |
Does not detect fungal species that produce very low levels of (1-3) beta-D-glucan (eg, Cryptococcus) Does not detect Zygomycetes (ie, Absidia, Mucor, and Rhizopus) |
|
| Vaginal Pathogens DNA Direct Probes 0065153 Method: Qualitative Nucleic Acid Probe |
Use to detect common vaginal pathogens associated with vaginitis/vaginosis Not recommended as stand-alone test for sexually transmitted infection testing or screening Includes testing for Candida species, Gardnerella vaginalis, and Trichomonas vaginalis Sensitivity may vary with quality of specimen collection For Trichomonas vaginalis, preferred test is one of the nucleic acid amplification tests (NAAT) (ie, Trichomonas vaginalis by Amplified Detection) |
Poor clinical specificity; cannot distinguish colonization from active infection |
|
| Coccidioides Antibodies Panel, CSF by CF, ID, ELISA 0050710 Method: Semi-Quantitative Complement Fixation/Qualitative Immunodiffusion/Semi-Quantitative Enzyme-Linked Immunosorbent Assay |
Confirm coccidioidal disease as infectious agent in meningitis |
||
| Coccidioides Antibodies Panel, Serum by CF, ID, ELISA 0050588 Method: Semi-Quantitative Complement Fixation/Qualitative Immunodiffusion/Semi-Quantitative Enzyme-Linked Immunosorbent Assay |
Confirm coccidioidal disease as infectious agent Use to monitor response to therapy |
Negative fungal serology does not rule out possibility of current infection |
|
| Coccidioides immitis Identification by DNA Probe 0062225 Method: Nucleic Acid Probe |
Rapid test for identifying C. immitis (yeast or mold form) |
||
| Blastomyces dermatitidis Identification by DNA Probe 0062224 Method: Nucleic Acid Probe |
Rapid test for identifying B. dermatitidis (yeast or mold form) |
Gymmascella hyalinospora, a member of the Ascomycetes order, may cross-react with B. dermatitidis probes |
|
| Blastomyces dermatitidis Antigen EIA 2002926 Method: Quantitative Enzyme Immunoassay |
Diagnose and monitor B. dermatitidis |
||
| Blastomyces Antibodies by CF & ID 0050626 Method: Semi-Quantitative Complement Fixation/Qualitative Immunodiffusion |
Confirm Blastomyces as infectious agent |